慢性鼻窦炎嗅裂黏液炎性蛋白的病例对照研究
这项横断面病例对照研究评估了慢性鼻窦炎(CRS)患者嗅裂黏液炎性蛋白与嗅觉功能及CT嗅裂浑浊的关系。CRS患者(n=151)中23/26种蛋白浓度显著高于对照(n=74),CCL2、CCL3、IL5、IL10、IL13异常与更重嗅觉缺陷相关,IL5和IL13在鼻息肉型CRS中升高最显著。
要点
- CRS患者嗅裂黏液多数炎性蛋白浓度显著升高
- IL5和IL13异常与嗅觉缺陷及嗅裂浑浊相关
- 部分不伴鼻息肉CRS患者也表达2型炎性介质
核心结论
- 嗅裂炎性蛋白因疾病表型不同而异,且与嗅觉功能障碍相关。
- 2型炎性介质在CRS中升高,尤其在伴鼻息肉组,但相当比例不伴鼻息肉患者也表达。
研究设计与样本
- 横断面病例对照研究,纳入CRS病例151例和对照74例。
- 评估嗅裂黏液炎性蛋白、心理物理嗅觉测试及嗅裂与鼻窦CT分析。
主要发现
- CRS队列中26种蛋白有23种浓度显著高于对照。
- CCL2、CCL3、IL5、IL10、IL13异常水平与更重嗅觉缺陷相关。
- 嗅觉丧失患者中IL5和IL13升高比例分别为64.6%和62.5%(p<0.004)。
- CRSwNP中升高表达比值比最高为IL5(OR=10.83)和IL13(OR=8.36)。
- 约14%的CRSsNP患者IL5和IL13仍升高。
关键数值与推荐
- CRSwNP中IL5升高OR=10.83,IL13升高OR=8.36。
- 嗅觉丧失患者IL5升高占64.6%、IL13升高占62.5%(p<0.004)。
- 约14%的CRSsNP患者IL5和IL13升高。
- 嗅裂总浑浊百分比与IL5相关r=0.543(p<0.001)。
临床怎么用
- 嗅裂黏液炎性蛋白检测有助于区分CRS表型与嗅觉障碍风险。
- 不伴鼻息肉CRS也应关注2型炎性介质表达。
局限性
- 横断面设计无法确定因果关系。
- 需进一步研究以理解嗅裂黏液炎性蛋白在内型定义和CRS相关嗅觉障碍中的复杂作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multiple hypotheses are evolving that suggest several, potentially overlapping etiologies for olfactory dysfunction (OD) in chronic rhinosinusitis (CRS). Understanding inflammatory cytokine profiles of the olfactory cleft (OC) and their association with olfactory function is foundational for future clinical care and research. METHODS: This cross-sectional, case-control study evaluates associations among OC mucus inflammatory proteins, psychophysical olfactory testing, and computed tomography (CT) analysis of the OC and sinuses. Normative reference intervals were determined for each protein and odds ratios (ORs) were used to compare proportions of altered expression between CRS without nasal polyposis (CRSsNP) and CRS without nasal polyposis (CRSwNP). RESULTS: Case subjects with CRS (n = 151) and controls (n = 74) were evaluated. A majority of OC proteins tested were found within detectable ranges for cases and controls. The CRS cohort had significantly higher concentrations for 23 of 26 proteins. CRS cases with abnormal levels of C-C motif chemokine ligand 2 (CCL2), CCL3, interleukin 5 (IL5), IL10, and IL13 associated with greater olfactory deficits. The prevalence of elevated IL5 and IL13 in anosmic patients was 64.6% and 62.5%, respectively (p < 0.004). CRS cases with the highest odds of elevated expression in CRSwNP were IL5 (OR = 10.83) and IL13 (OR = 8.36). However, both IL5 and IL13 were still elevated in approximately 14% of CRSsNP patients. The highest magnitude of correlation between the total percent of OC opacification was found to be with IL5 (r = 0.543; p < 0.001), whereas other moderate correlations were noted with immunoglobulin E (IgE), IL10, and IL13. CONCLUSION: This study confirmed that OC inflammatory proteins vary both by disease phenotype and in their association with OD. Type 2 inflammatory mediators are increased in CRS, especially within the CRSwNP group. However, a substantial proportion of CRSsNP also express type 2 inflammatory mediators. Further research is necessary to understand the complex roles OC mucous inflammatory proteins might play in defining endotype and in impacting CRS-related OD. ©2021 ARSAAOA, LLC.
引用
- Smith TL, Schlosser RJ, Soler ZM, et al. Olfactory cleft mucus inflammatory proteins in CRS: a case-control study. Int Forum Allergy Rhinol. 2021. PMID: 33629532. doi:10.1002/alr.22770
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。